| Literature DB >> 28888322 |
Abstract
Michael N. Hall is this year's recipient of the Lasker Basic Medical Research Award for the identification of the target of rapamycin, TOR. TOR is a master regulator of the cell's growth and metabolic state, and its dysregulation contributes to a variety of diseases, including diabetes, obesity, neurodegenerative disorders, aging, and cancer, making the TOR pathway an attractive therapeutic target.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28888322 DOI: 10.1016/j.cell.2017.08.019
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582